TMC Life Sciences Bhd (XKLS:0101) EPS without NRI: RM0.01 (TTM As of Mar. 2026)


XKLS:0101 TMC Life Sciences Bhd XKLS:0101
60 GF Score
Price RM0.47
GF Value RM0.62
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is TMC Life Sciences Bhd EPS without NRI?

TMC Life Sciences Bhd XKLS:0101 +1.09% 60 EPS without NRI is RM0.01 as of Mar. 2026. GuruFocus rates XKLS:0101 with a GF Score™ of 60/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 513 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 94.93% on this metric.

TMC Life Sciences Bhd's earnings per share without non-recurring items for the three months ended in Mar. 2026 was RM0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.01.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -56.30% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for TMC Life Sciences Bhd's EPS without NRI or its related term are showing as below:

XKLS:0101' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.3   Med: 22.4   Max: 44.2
Current: -56.3

During the past 13 years, TMC Life Sciences Bhd's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 44.20% per year. The lowest was -56.30% per year. And the median was 22.40% per year.

XKLS:0101's 3-Year EPS without NRI Growth Rate is ranked worse than
94.93% of 513 companies
in the Healthcare Providers & Services industry
Industry Median: 11.6 vs XKLS:0101: -56.30

TMC Life Sciences Bhd's EPS (Diluted) for the three months ended in Mar. 2026 was RM0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.01.

TMC Life Sciences Bhd's EPS (Basic) for the three months ended in Mar. 2026 was RM0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.01.


TMC Life Sciences Bhd  (XKLS:0101) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


TMC Life Sciences Bhd EPS without NRI Related Terms


TMC Life Sciences Bhd EPS without NRI Historical Data

* Premium members only.

The historical data trend for TMC Life Sciences Bhd's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TMC Life Sciences Bhd EPS without NRI Chart

TMC Life Sciences Bhd Annual Data
Trend May15 May16 Aug17 Aug18 Aug19 Jun21 Jun22 Jun23 Jun24 Jun25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.02 0.02 0.00

TMC Life Sciences Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00

XKLS:0101 vs HCA, THC, DVA: EPS without NRI Comparison

For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TMC Life Sciences Bhd PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where TMC Life Sciences Bhd's PE Ratio without NRI falls into.


XKLS:0101
60GF Score
TMC Life Sciences Bhd XKLS:0101
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TMC Life Sciences Bhd EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of RM0.01 mean?
TMC Life Sciences Bhd (XKLS:0101) has a EPS without NRI of RM0.01 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on TMC Life Sciences Bhd and its competitors. According to the industry distribution chart, TMC Life Sciences Bhd ranks #487 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 94.9%.
Is TMC Life Sciences Bhd's EPS without NRI too high?
TMC Life Sciences Bhd's current EPS without NRI is RM0.01. Based on the distribution chart, TMC Life Sciences Bhd ranks #487 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's EPS without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #487 out of 513 companies for EPS without NRI. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median EPS without NRI is 11.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.60, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current EPS without NRI is RM0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.47 — trading 25% below its estimated fair value. The current EPS without NRI is RM0.01. TMC Life Sciences Bhd's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current EPS without NRI is RM0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?

Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued. The current stock price of RM0.47 is trading 25% below its estimated GF Value™ of RM0.62. GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0101:

  • EPS without NRI: RM0.01
  • GF Value™: RM0.62 vs. price of RM0.47 (25% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TMC Life Sciences Bhd Business Description

Address No. 11, PJU 5, Jalan Teknologi, Level 11, Taman Sains, Kota Damansara, Petaling Jaya, SGR, MYS, 47810
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
60GF Score

Get the complete analysis for XKLS:0101

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.47
Price
RM0.62
GF Value